Donaueschingen (pta/08.11.2022/08:52 UTC+1)
08/11/2022: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 10% and EBIT by approx. 24% in the first nine months of 2022. As a result, the continually positive development of sales and earnings of the last years could be continued.
Sales improved from KEUR 137,223 to KEUR 150,790 (+9.9%) in the first nine months 2022. The international share of total business volume was 47.5% (9M-2021: 46.1%) and amounted to KEUR 71,551 compared to KEUR 63,268 (9M-2021).
The consolidated surplus rose very sharply by 24.6% to KEUR 13,845 (9M-2021: KEUR 11,110), and consolidated earnings before interest and taxes (EBIT) rose by 24.1% to KEUR 18,794 (9M-2021: KEUR 15,140): EBITA increased by 19.9% from KEUR 18,639 (9M-2021) to KEUR 22,351, and EBITDA increased by 13.2% to KEUR 31,236 (9M-2021 KEUR 27,605).
Cash flow from operating activities amounted to KEUR 30,948 (9M 2021: KEUR 24,727) in the first nine months of the year 2022, which is 25.2 % higher than in the previous year.
As of 30/09/2022, the company had cash resources at its disposal in the amount of KEUR 109,783 (31/12/2021: KEUR 26,172). Nexus AG had equity capital amounting to KEUR 234,931 as of 30/09/2022 (31/12/2021: KEUR 142,403). Consequently, the equity capital rate is 70.4% (31/12/2021: 57.6%).
|Contact Person:||Hannes Wehinger|
|Phone:||+49 771 22960-260|
|Stock Exchange(s):||Regulated Market in Frankfurt, Regulated Market in Hamburg, Free Market in Berlin, Free Market in Dusseldorf, Free Market in Munich, Free Market in Stuttgart|